NeoGenomics, Inc. (NEO)

CIK 0001077183 · Healthcare · Diagnostics and Research

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-07-28) · 99.1
Q1-2026 8-K (2026-04-28) · 99.1
Latest FY-2025 8-K (2026-02-17) · 99.1  |  8-K (2026-01-12) · 99.1
Q3-2025 8-K (2025-10-28) · 99.1
Q2-2025 8-K (2025-07-29) · 99.1
Q1-2025 8-K (2025-04-29) · 99.1
FY-2024 8-K (2025-02-18) · 99.1
Q3-2024 8-K (2024-11-05) · 99.1
Q2-2024 8-K (2024-07-29) · 99.1
Q1-2024 8-K (2024-04-30) · 99.1
FY-2023 8-K (2024-02-20) · 99.1
Q3-2023 8-K (2023-11-06) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Condensed Consolidated Statements of Comprehensive Income (loss)
—
Consolidated Statements of Comprehensive Loss
Consolidated Statements of Stockholders Equity
Consolidated Statements of Cash Flows
Notes
Acquisitions and Disposals
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Debt
Defined Contribution Plan
—
Equity Transactions
Fair Value Measurements
Goodwill and Intangible Assets
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Leases
—
Nature of Business
—
Nature of The Business
—
Net Income (loss) Per Share
—
Net Loss Per Share
Pay Vs Performance Disclosure
Property and Equipment, Net
—
Related Party Transactions
Restructuring
Revenue Recognition
Segment Information
Stock-based Compensation
Subsequent Events
—
Summary of Significant Accounting Policies